Few Patients With IBD Receive Early Vedolizumab Few Patients With IBD Receive Early Vedolizumab

Earlier treatment is associated with increased likelihood of response and remission, but in clinical practice, biologic agents are often delayed.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news
More News: Gastroenterology